KNSA
Kiniksa Pharmaceuticals International, plc
+1.28 (+1.66%)78.91USD189K成交股數6.5B市值86.7本益比(近四季)8.6股價營收比+55.5%營收年增(近四季)2026-10-27下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 2 · 668K · 2 |
| 其中 10b5-1 計畫賣出 | 1 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 34.7M |
| 近 180 天 淨額 | −34.7M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 | 09-03 | Megna Michael R | CHIEF ACCOUNTING OFFICER | S 公開市場賣出(10b5-1) | 4.6K | 80.30 | 369K | 29.1K | SEC |
| 2026-09-01 | 09-03 | Patel Sanj K | CHAIRMAN & CEO | M 選擇權執行 | 8.6K | – | – | 107K | SEC |
| 2026-09-01 | 09-03 | Ragosa Mark | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 3.1K | – | – | 25.3K | SEC |
| 2026-09-01 | 09-03 | Megna Michael R | CHIEF ACCOUNTING OFFICER | M 選擇權執行 | 2.6K | – | – | 34.2K | SEC |
| 2026-09-01 | 09-03 | Patel Sanj K | CHAIRMAN & CEO | M 選擇權執行 | 10.0K | – | – | 86.2K | SEC |
| 2026-09-01 | 09-03 | Megna Michael R | CHIEF ACCOUNTING OFFICER | M 選擇權執行 | 2.6K | – | – | 39.2K | SEC |
| 2026-09-01 | 09-03 | Paolini John F. | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 4.0K | 79.28 | 319K | 69.9K | SEC |
| 2026-09-01 | 09-03 | Megna Michael R | CHIEF ACCOUNTING OFFICER | M 選擇權執行 | 2.4K | – | – | 36.5K | SEC |
| 2026-09-01 | 09-03 | Patel Sanj K | CHAIRMAN & CEO | M 選擇權執行 | 6.5K | – | – | 92.6K | SEC |
| 2026-09-01 | 09-03 | Moat Ross | CHIEF OPERATING OFFICER | F 繳稅扣股 | 4.0K | 79.28 | 318K | 16.3K | SEC |
| 2026-09-01 | 09-03 | Megna Michael R | CHIEF ACCOUNTING OFFICER | F 繳稅扣股 | 5.5K | 79.28 | 438K | 33.7K | SEC |
| 2026-09-01 | 09-03 | Patel Sanj K | CHAIRMAN & CEO | F 繳稅扣股 | 15.1K | 79.28 | 1.2M | 92.3K | SEC |
| 2026-09-01 | 09-03 | Moat Ross | CHIEF OPERATING OFFICER | M 選擇權執行 | 1.7K | – | – | 17.9K | SEC |
| 2026-09-01 | 09-03 | Paolini John F. | CHIEF MEDICAL OFFICER | M 選擇權執行 | 1.8K | – | – | 71.5K | SEC |
| 2026-09-01 | 09-03 | Megna Michael R | CHIEF ACCOUNTING OFFICER | M 選擇權執行 | 3.9K | – | – | 31.6K | SEC |
| 2026-09-01 | 09-03 | Moat Ross | CHIEF OPERATING OFFICER | M 選擇權執行 | 2.5K | – | – | 14.5K | SEC |
| 2026-09-01 | 09-03 | Moat Ross | CHIEF OPERATING OFFICER | M 選擇權執行 | 1.6K | – | – | 16.1K | SEC |
| 2026-09-01 | 09-03 | Patel Sanj K | CHAIRMAN & CEO | M 選擇權執行 | 6.5K | – | – | 92.6K | SEC |
| 2026-09-01 | 09-03 | Patel Sanj K | CHAIRMAN & CEO | M 選擇權執行 | 6.2K | – | – | 98.9K | SEC |
| 2026-09-01 | 09-03 | Paolini John F. | CHIEF MEDICAL OFFICER | M 選擇權執行 | 2.5K | – | – | 68.1K | SEC |
| 2026-09-01 | 09-03 | Patel Sanj K | CHAIRMAN & CEO | M 選擇權執行 | 8.6K | – | – | 107K | SEC |
| 2026-09-01 | 09-03 | Patel Sanj K | CHAIRMAN & CEO | M 選擇權執行 | 6.2K | – | – | 98.9K | SEC |
| 2026-09-01 | 09-03 | Ragosa Mark | CHIEF FINANCIAL OFFICER | F 繳稅扣股 | 4.4K | 79.28 | 349K | 20.9K | SEC |
| 2026-09-01 | 09-03 | Ragosa Mark | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 2.7K | – | – | 18.8K | SEC |
| 2026-09-01 | 09-03 | Moat Ross | CHIEF OPERATING OFFICER | M 選擇權執行 | 2.5K | – | – | 20.3K | SEC |
| 2026-09-01 | 09-03 | Patel Sanj K | CHAIRMAN & CEO | F 繳稅扣股 | 15.1K | 79.28 | 1.2M | 92.3K | SEC |
| 2026-09-01 | 09-03 | Paolini John F. | CHIEF MEDICAL OFFICER | M 選擇權執行 | 1.6K | – | – | 69.7K | SEC |
| 2026-09-01 | 09-03 | Ragosa Mark | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 1.8K | – | – | 20.6K | SEC |
| 2026-09-01 | 09-03 | Paolini John F. | CHIEF MEDICAL OFFICER | M 選擇權執行 | 2.5K | – | – | 74.0K | SEC |
| 2026-09-01 | 09-03 | Ragosa Mark | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 1.6K | – | – | 22.2K | SEC |
| 2026-09-01 | 09-03 | Patel Sanj K | CHAIRMAN & CEO | M 選擇權執行 | 10.0K | – | – | 86.2K | SEC |
| 2026-08-19 | 08-21 | Quart Barry D | Director | G 贈與 | 2.6K | – | – | 12.7K | SEC |
| 2026-08-01 | 08-04 | Levy Richard S | Director | M 選擇權執行 | 403 | – | – | 22.4K | SEC |
| 2026-07-29 | 07-31 | Cole G Bradley | Director | G 贈與 | 4.5K | – | – | 7.2K | SEC |
| 2026-07-29 | 07-31 | Cole G Bradley | Director | S 公開市場賣出 | 3.7K | 81.43 | 299K | 11.7K | SEC |
| 2026-07-15 | 09-03 | Megna Michael R | CHIEF ACCOUNTING OFFICER | A 獲配股票 | 279 | 33.50 | 9K | 27.7K | SEC |
| 2026-06-01 | 06-02 | Patel Sanj K | CHAIRMAN & CEO | C 轉換 | 900K | – | – | 952K | SEC |
| 2026-05-29 | 06-02 | Baker Bros. Advisors (GP) LLC | Director | A 獲配股票 | 6.1K | – | – | 2.7M | SEC |
| 2026-05-29 | 06-02 | BAKER JULIAN | Director | A 獲配股票 | 6.1K | – | – | 143K | SEC |
| 2026-05-29 | 06-02 | McCain Tracey L | Director | M 選擇權執行 | 2.8K | – | – | 15.3K | SEC |
| 2026-05-29 | 06-02 | Levy Richard S | Director | M 選擇權執行 | 2.8K | – | – | 22.0K | SEC |
| 2026-05-29 | 06-02 | Malley Thomas | Director | M 選擇權執行 | 2.8K | – | – | 15.3K | SEC |
| 2026-05-29 | 06-02 | Quart Barry D | Director | M 選擇權執行 | 2.8K | – | – | 15.3K | SEC |
| 2026-05-29 | 06-02 | Cole G Bradley | Director | M 選擇權執行 | 2.8K | – | – | 15.3K | SEC |
| 2026-05-29 | 06-02 | Popovits Kimberly J | Director | M 選擇權執行 | 2.8K | – | – | 15.3K | SEC |
| 2026-05-29 | 06-02 | Baker Bros. Advisors (GP) LLC | Director | A 獲配股票 | 6.1K | – | – | 143K | SEC |
| 2026-05-29 | 06-02 | 667, L.P. | Director | A 獲配股票 | 6.1K | – | – | 2.7M | SEC |
| 2026-05-29 | 06-02 | 667, L.P. | Director | A 獲配股票 | 6.1K | – | – | 143K | SEC |
| 2026-05-29 | 06-02 | Baker Brothers Life Sciences LP | Director | A 獲配股票 | 6.1K | – | – | 2.7M | SEC |
| 2026-05-29 | 06-02 | Baker Brothers Life Sciences LP | Director | A 獲配股票 | 6.1K | – | – | 143K | SEC |
| 2026-05-29 | 06-02 | BAKER BROS. ADVISORS LP | Director | A 獲配股票 | 6.1K | – | – | 2.7M | SEC |
| 2026-05-29 | 06-02 | BAKER BROS. ADVISORS LP | Director | A 獲配股票 | 6.1K | – | – | 143K | SEC |
| 2026-05-29 | 06-02 | BAKER FELIX | Director | A 獲配股票 | 6.1K | – | – | 2.7M | SEC |
| 2026-05-29 | 06-02 | BAKER FELIX | Director | A 獲配股票 | 6.1K | – | – | 143K | SEC |
| 2026-05-29 | 06-02 | BAKER JULIAN | Director | A 獲配股票 | 6.1K | – | – | 2.7M | SEC |
| 2026-05-01 | 05-05 | Paolini John F. | CHIEF MEDICAL OFFICER | M 選擇權執行 | 58.4K | 10.36 | 605K | 124K | SEC |
| 2026-05-01 | 05-05 | Paolini John F. | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 37.3K | 53.52 | 2.0M | 86.7K | SEC |
| 2026-05-01 | 05-05 | Paolini John F. | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 21.1K | 54.04 | 1.1M | 65.6K | SEC |
| 2026-05-01 | 05-01 | Patel Sanj K | CHAIRMAN & CEO | S 公開市場賣出(10b5-1) | 48.6K | 54.02 | 2.6M | 0 | SEC |
| 2026-05-01 | 05-01 | Patel Sanj K | CHAIRMAN & CEO | M 選擇權執行 | 48.6K | 30.93 | 1.5M | 48.6K | SEC |
| 2026-04-30 | 04-30 | Patel Sanj K | CHAIRMAN & CEO | S 公開市場賣出(10b5-1) | 2.1K | 54.01 | 116K | 0 | SEC |
| 2026-04-30 | 04-30 | Patel Sanj K | CHAIRMAN & CEO | M 選擇權執行 | 2.1K | 30.93 | 66K | 2.1K | SEC |
| 2026-04-29 | 04-30 | Patel Sanj K | CHAIRMAN & CEO | S 公開市場賣出(10b5-1) | 22.5K | 54.01 | 1.2M | 0 | SEC |
| 2026-04-29 | 04-30 | Patel Sanj K | CHAIRMAN & CEO | M 選擇權執行 | 22.5K | 30.93 | 697K | 22.5K | SEC |
| 2026-04-28 | 04-30 | Patel Sanj K | CHAIRMAN & CEO | S 公開市場賣出(10b5-1) | 74.6K | 50.43 | 3.8M | 409K | SEC |
| 2026-04-28 | 04-30 | Patel Sanj K | CHAIRMAN & CEO | M 選擇權執行 | 51.8K | 30.93 | 1.6M | 484K | SEC |
| 2026-04-28 | 04-30 | Patel Sanj K | CHAIRMAN & CEO | S 公開市場賣出(10b5-1) | 114K | 51.47 | 5.9M | 295K | SEC |
| 2026-04-28 | 04-30 | Patel Sanj K | CHAIRMAN & CEO | M 選擇權執行 | 432K | 10.36 | 4.5M | 432K | SEC |
| 2026-04-28 | 04-30 | Patel Sanj K | CHAIRMAN & CEO | S 公開市場賣出(10b5-1) | 51.8K | 54.02 | 2.8M | 0 | SEC |
| 2026-04-28 | 04-30 | Patel Sanj K | CHAIRMAN & CEO | S 公開市場賣出(10b5-1) | 244K | 52.02 | 12.7M | 51.8K | SEC |
| 2026-04-28 | 04-29 | Quart Barry D | Director | M 選擇權執行 | 13.1K | 14.33 | 188K | 25.6K | SEC |
| 2026-04-28 | 04-29 | Quart Barry D | Director | S 公開市場賣出(10b5-1) | 13.1K | 50.10 | 656K | 12.5K | SEC |
| 2026-04-09 | 04-13 | Moat Ross | CHIEF OPERATING OFFICER | S 公開市場賣出(10b5-1) | 1.7K | 46.69 | 80K | 12.0K | SEC |
| 2026-04-09 | 04-13 | Megna Michael R | CHIEF ACCOUNTING OFFICER | S 公開市場賣出(10b5-1) | 6.6K | 46.69 | 309K | 27.4K | SEC |
| 2026-04-07 | 04-08 | Patel Sanj K | CHAIRMAN & CEO | F 繳稅扣股 | 4.8K | 48.94 | 236K | 76.2K | SEC |
| 2026-04-07 | 04-08 | Megna Michael R | CHIEF ACCOUNTING OFFICER | F 繳稅扣股 | 1.7K | 48.94 | 82K | 34.0K | SEC |
| 2026-04-07 | 04-08 | Megna Michael R | CHIEF ACCOUNTING OFFICER | M 選擇權執行 | 3.9K | 1.00 | 4K | 35.7K | SEC |
| 2026-04-07 | 04-08 | Patel Sanj K | CHAIRMAN & CEO | M 選擇權執行 | 10.0K | – | – | 81.0K | SEC |
| 2026-04-07 | 04-08 | Paolini John F. | CHIEF MEDICAL OFFICER | M 選擇權執行 | 2.5K | – | – | 66.8K | SEC |
| 2026-04-07 | 04-08 | Paolini John F. | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 1.2K | 48.94 | 59K | 65.6K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 7.0M | 446M | +148K (+2%) | 加碼 |
| Rubric Capital Management LP | 4.0M | 256M | +250K (+7%) | 加碼 |
| BAKER BROS. ADVISORS LP | 2.8M | 181M | +8.4K (+0%) | 加碼 |
| BlackRock, Inc. | 2.7M | 175M | +2.3M (+463%) | 加碼 |
| TANG CAPITAL MANAGEMENT LLC | 2.3M | 145M | 不變 | 持平 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.9M | 122M | +145K (+8%) | 加碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.4M | 87.0M | +27.7K (+2%) | 加碼 |
| MORGAN STANLEY | 1.0M | 64.7M | +13.4K (+1%) | 加碼 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 958K | 61.2M | +64.8K (+7%) | 加碼 |
| Spruce Street Capital LP | 918K | 58.7M | +157K (+21%) | 加碼 |
| DIMENSIONAL FUND ADVISORS LP | 875K | 55.9M | +62.9K (+8%) | 加碼 |
| Invesco Ltd. | 773K | 49.4M | +745K (+2694%) | 加碼 |
| Driehaus Capital Management LLC | 718K | 45.9M | +107K (+17%) | 加碼 |
| STATE STREET CORP | 704K | 45.0M | +628K (+819%) | 加碼 |
| Point72(柯恩) Point72 Asset Management, L.P. | 659K | 42.2M | +18.5K (+3%) | 加碼 |
| RICE HALL JAMES & ASSOCIATES, LLC | 625K | 40.0M | +16.5K (+3%) | 加碼 |
| Pictet Asset Management Holding SA | 609K | 38.9M | −14.6K (-2%) | 減碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 604K | 38.6M | +560K (+1263%) | 加碼 |
| Jupiter Topco LLC | 586K | 37.5M | 新進 | 新進 |
| Connor, Clark & Lunn Investment Management Ltd. | 573K | 36.6M | −77.0K (-12%) | 減碼 |
| 德劭 D. E. Shaw & Co., Inc. | 570K | 36.4M | −390K (-41%) | 減碼 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 561K | 35.9M | +141K (+33%) | 加碼 |
| VICTORY CAPITAL MANAGEMENT INC | 505K | 32.3M | −1.7K (-0%) | 減碼 |
| BNP PARIBAS FINANCIAL MARKETS | 437K | 28.0M | −211K (-33%) | 減碼 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 431K | 27.6M | −6.7K (-2%) | 減碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 269 +42 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 73 / 31 / 81 / 77 |
| 機構合計持股 · 佔流通股 | 46.9M · 57.0% |
| 合計季末市值 | 2.9B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 3.8M |
|---|---|
| 與上期比 | -11.6% |
| 佔流通股數 | 4.60% |
| 日均成交量 | 436K |
| 回補天數 | 8.7 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 3.8M | -11.6% | 4.60% | 436K | 8.7 |
| 2026-08-14 | 4.3M | -0.8% | 5.20% | 448K | 9.6 |
| 2026-07-31 | 4.3M | -4.3% | 5.24% | 865K | 5.0 |
| 2026-07-15 | 4.5M | +8.6% | 5.47% | 659K | 6.9 |
| 2026-06-30 | 4.2M | +41.0% | 5.04% | 1.4M | 2.9 |
| 2026-06-15 | 2.9M | -3.1% | 3.58% | 515K | 5.7 |
| 2026-05-29 | 3.0M | -4.2% | 3.69% | 547K | 5.6 |
| 2026-05-15 | 3.2M | -10.0% | 3.85% | 572K | 5.6 |
| 2026-04-30 | 3.5M | -13.8% | 4.28% | 1.1M | 3.2 |
| 2026-04-15 | 4.1M | +0.1% | 4.97% | 567K | 7.2 |
| 2026-03-31 | 4.1M | +8.6% | 4.96% | 603K | 6.8 |
| 2026-03-13 | 3.8M | +11.3% | 4.57% | 739K | 5.1 |
| 2026-02-27 | 3.4M | +10.7% | 4.11% | 615K | 5.5 |
| 2026-02-13 | 3.1M | -0.3% | 3.71% | 389K | 7.9 |
| 2026-01-30 | 3.1M | -8.8% | 3.72% | 727K | 4.2 |
| 2026-01-15 | 3.4M | -5.9% | 4.08% | 729K | 4.6 |
| 2025-12-31 | 3.6M | +15.0% | 4.33% | 389K | 9.2 |
| 2025-12-15 | 3.1M | +10.8% | 3.77% | 384K | 8.1 |
| 2025-11-28 | 2.8M | -2.9% | 3.40% | 353K | 7.9 |
| 2025-11-14 | 2.9M | +2.1% | 3.50% | 348K | 8.3 |
| 2025-10-31 | 2.8M | +10.4% | 3.43% | 653K | 4.3 |
| 2025-10-15 | 2.6M | +1.7% | 3.11% | 369K | 6.9 |
| 2025-09-30 | 2.5M | +3.5% | 3.06% | 403K | 6.3 |
| 2025-09-15 | 2.4M | -10.1% | 2.95% | 473K | 5.2 |
| 2025-08-29 | 2.7M | +29.4% | 3.29% | 379K | 7.2 |
| 2025-08-15 | 2.1M | -13.9% | 2.54% | 684K | 3.1 |